Safety and efficacy of autologous tumor lysate particle loaded dendritic cell (TLPLDC) vaccination in combination with systemic therapies in patients with metastatic melanoma

被引：0
|
作者：
Chick, Robert Connor [1 ]
Hickerson, Annelies T. [1 ]
Clifton, Guy Travis [1 ]
Bohan, Phillip M. Kemp [1 ]
Brown, Tommy A. [1 ]
Cindass, Jessica L. [1 ]
Myers, John W. [1 ]
Vreeland, Timothy J. [1 ]
Jackson, Doreen O. [1 ]
Hale, Diane F. [1 ]
Peace, Kaitlin M. [1 ]
Herbert, Garth S. [2 ]
Yu, Xianzhong [3 ]
Wagner, Thomas [4 ]
Peoples, George E. [5 ]
机构：
[1] Brooke Army Med Ctr, Ft Sam Houston, TX 78234 USA
[2] Duke Univ, Durham, NC USA
[3] Clemson Univ, Clemson, SC USA
[4] Perseus PCI, Greenville, SC USA
[5] Canc Insight, San Antonio, TX USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-6536
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6536
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Safety and efficacy of autologous tumor lysate particle-loaded dendritic cell vaccination in combination with systemic therapies in patients with recurrent and metastatic melanoma
    Adams, Alexandra M.
    Chick, Robert C.
    Vreeland, Timothy J.
    Clifton, Guy T.
    Hale, Diane F.
    McCarthy, Patrick M.
    O'Shea, Anne E.
    Bohan, Phillip M. Kemp
    Hickerson, Annelies T.
    Park, Hyohyun
    Sloan, Amanda JoEllen
    Hyngstrom, John
    Berger, Adam C.
    Jakub, James W.
    Sussman, Jeffrey J.
    Shaheen, Montaser
    Wagner, Thomas
    Faries, Mark B.
    Peoples, George E.
    MELANOMA RESEARCH, 2021, 31 (04) : 378 - 388
  • [2] Clinical efficacy of vaccination with the autologous tumor lysate particle loaded dendritic cell (TLPLDC) vaccine in metastatic melanoma.
    Hickerson, Annelies
    Clifton, Guy T.
    Brown, Tommy A.
    Campf, Jessica
    Myers, John William
    Vreeland, Timothy J.
    Hale, Diane F.
    Peace, Kaitlin M.
    Jackson, Doreen O.
    Yu, Xianzhong
    Wagner, Thomas
    Peoples, George Earl
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] Prior vaccination with the autologous Tumor Lysate Particle Loaded Dendritic Cell (TLPLDC) Vaccine may impact clinical outcomes in melanoma patients treated with systemic therapies and re-vaccination
    Hickerson, Annelies T.
    Clifton, Guy T.
    Brown, Tommy A.
    Cindass, Jessica L.
    Myers, John W.
    Vreeland, Timothy J.
    Hale, Diane F.
    Peace, Kaitlin M.
    Jackson, Doreen O.
    Herbert, Garth
    Yu, Xianzhong
    Wagner, Thomas E.
    Peoples, George E.
    CANCER RESEARCH, 2019, 79 (13)
  • [4] Early trial results of an autologous tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine in ovarian cancer patients
    Peace, Kaitlin M.
    Vreeland, Timothy J.
    Clifton, Guy T.
    Hale, Diane F.
    Jackson, Doreen O.
    Berry, John S.
    Trappey, Alfred F.
    Herbert, Garth S.
    Hardin, Mark O.
    Nichol, Pauline T.
    Yin, Sook L.
    Yu, Xianzhong
    Wagner, Thomas E.
    Peoples, George E.
    CANCER RESEARCH, 2017, 77
  • [5] Initial Results of a Phase I andII: A trial of Tumor Lysate Particle Loaded Dendritic Cell (TLPLDC) Vaccine Combined with Checkpoint Inhibitors in Metastatic Melanoma
    Myers, J. W.
    Clifton, G. T.
    Vreeland, T. J.
    Brown, T. A.
    Peace, K. M.
    Greene, J. M.
    Jackson, D. O.
    Hale, D. F.
    Berry, J. S.
    O'Day, S. J.
    Peoples, G. E.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : S180 - S180
  • [6] Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate
    Margarita Salcedo
    Nadège Bercovici
    Rachel Taylor
    Pierre Vereecken
    Séverine Massicard
    Dominique Duriau
    Frédérique Vernel-Pauillac
    Aurélie Boyer
    Véronique Baron-Bodo
    Eric Mallard
    Jacques Bartholeyns
    Béatrice Goxe
    Nathalie Latour
    Sophie Leroy
    Didier Prigent
    Philippe Martiat
    François Sales
    Marianne Laporte
    Catherine Bruyns
    Jean-Loup Romet-Lemonne
    Jean-Pierre Abastado
    Frédéric Lehmann
    Thierry Velu
    Cancer Immunology, Immunotherapy, 2006, 55 : 819 - 829
  • [7] Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate
    Salcedo, M
    Bercovici, N
    Taylor, R
    Vereecken, P
    Massicard, S
    Duriau, D
    Vernel-Pauillac, F
    Boyer, A
    Baron-Bodo, V
    Mallard, E
    Bartholeyns, J
    Goxe, B
    Latour, N
    Leroy, S
    Prigent, D
    Martiat, P
    Sales, F
    Laporte, M
    Bruyns, C
    Romet-Lemonne, JL
    Abastado, JP
    Lehmann, F
    Velu, T
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2006, 55 (07) : 819 - 829
  • [8] Initial phase I/IIa trial results of an autologous tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine in patients with solid tumors
    Herbert, Garth S.
    Vreeland, Timothy J.
    Clifton, Guy T.
    Greene, Julia M.
    Jackson, Doreen O.
    Hardin, Mark O.
    Hale, Diane F.
    Berry, John S.
    Nichol, Pauline
    Yin, Sook
    Yu, Xianzhong
    Wagner, Thomas E.
    Peoples, George E.
    VACCINE, 2018, 36 (23) : 3247 - 3253
  • [9] Initial phase I/IIa trial results of an autologous tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine in patients with solid tumors
    Herbert, Garth S.
    Greene, Julia M.
    Berry, John S.
    Jackson, Doreen O.
    Vreeland, Timothy J.
    Hale, Diane F.
    Schneble, Erica J.
    Nichol, Pauline
    Yin, Sook
    Yu, Xianzhong
    Wagner, Thomas
    Peoples, George Earl
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [10] Vaccination with autologous dendritic cells (DC) pulsed with autologous tumor lysate in patients (PTS) with metastatic melanoma (MM) and renal cell carcinoma (MRCC)
    Guida, M.
    Casamassima, A.
    Scelsi, M.
    Montemurro, S.
    Giudice, G.
    Misino, A.
    Porcelli, G.
    Zito, A.
    D'Errico, D.
    Quaranta, M.
    Lorusso, V.
    ANNALS OF ONCOLOGY, 2005, 16 : 153 - 154
12345